1IA
MRNA icon

1834 Investment Advisors’s Moderna MRNA Stock Holding History

1834 Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70
Closed -$10K – 355
2022
Q2 		$10K Hold
70
– – ﹤0.01% 377
2022
Q1 		$12K Sell
70
-15
-18% -$2.52K ﹤0.01% 342
2021
Q4 		$22K Sell
85
-585
-87% -$171K ﹤0.01% 323
2021
Q3 		$258K Sell
670
-5,249
-89% -$1.94M 0.03% 174
2021
Q2 		$1.39M Buy
5,919
+4,594
+347% +$821K 0.17% 92
2021
Q1 		$174K Buy
1,325
+655
+98% +$94.9K 0.02% 209
2020
Q4 		$70K Buy
670
+600
+857% +$60.7K 0.01% 251
2020
Q3 		$5K Buy
+70
New +$4.88K ﹤0.01% 385

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1834 Investment Advisors's MRNA Position: Q3 2022 in Review

1834 Investment Advisors sold out of Moderna (MRNA) in Q3 2022, closing a stake of 70 shares — an estimated $10K sold.

1834 Investment Advisors first reported a position in MRNA in Q3 2020 and held it in 8 quarters. The position peaked at $1.39M in Q2 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • 1834 Investment Advisors reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • 1834 Investment Advisors sold 70 Moderna shares in Q3 2022, an estimated $10K.
  • 1834 Investment Advisors first reported a position in Moderna in Q3 2020 and held it in 8 quarters.
  • 1834 Investment Advisors's Moderna position peaked at $1.39M in Q2 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.